{"id":"https://openalex.org/W4416764384","doi":"https://doi.org/10.1158/1535-7163.30733372","title":"Supplementary Table S1 from Endo180 (MRC2) Antibody\u2013Drug Conjugate for the Treatment of Sarcoma","display_name":"Supplementary Table S1 from Endo180 (MRC2) Antibody\u2013Drug Conjugate for the Treatment of Sarcoma","publication_year":2025,"publication_date":"2025-11-27","ids":{"openalex":"https://openalex.org/W4416764384","doi":"https://doi.org/10.1158/1535-7163.30733372"},"language":"en","primary_location":{"id":"doi:10.1158/1535-7163.30733372","doi":"https://doi.org/10.1158/1535-7163.30733372","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1535-7163.30733372","pdf_url":"https://aacr.figshare.com/articles/journal_contribution/Supplementary_Table_S1_from_Endo180_i_MRC2_i_Antibody_Drug_Conjugate_for_the_Treatment_of_Sarcoma/30733372/1/files/59895127.pdf","source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"volume":null,"type":"supplementary-materials","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://aacr.figshare.com/articles/journal_contribution/Supplementary_Table_S1_from_Endo180_i_MRC2_i_Antibody_Drug_Conjugate_for_the_Treatment_of_Sarcoma/30733372/1/files/59895127.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5045896494","display_name":"Rachel J. Evans","orcid":"https://orcid.org/0000-0003-3159-0405","observed_orcids":["https://orcid.org/0000-0003-3159-0405"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Rachel J. Evans","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0003-3159-0405","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5048536435","display_name":"Douglas W. Perkins","orcid":"https://orcid.org/0000-0002-3928-3971","observed_orcids":["https://orcid.org/0000-0002-3928-3971"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Douglas W. Perkins","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-3928-3971","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5036806948","display_name":"Joanna Selfe","orcid":"https://orcid.org/0000-0002-9556-3628","observed_orcids":["https://orcid.org/0000-0002-9556-3628"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Joanna Selfe","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-9556-3628","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5054708065","display_name":"Anna M. Kelsey","orcid":"https://orcid.org/0000-0003-3638-1266","observed_orcids":["https://orcid.org/0000-0003-3638-1266"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Anna Kelsey","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0003-3638-1266","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5073554716","display_name":"Gavin P. Birch","orcid":"https://orcid.org/0000-0002-8490-6138","observed_orcids":["https://orcid.org/0000-0002-8490-6138"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Gavin P. Birch","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-8490-6138","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5000054497","display_name":"JANET M. SHIPLEY","orcid":"https://orcid.org/0000-0001-6748-8678","observed_orcids":["https://orcid.org/0000-0001-6748-8678"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Janet M. Shipley","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-6748-8678","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5018628858","display_name":"Koen Schipper","orcid":"https://orcid.org/0000-0002-4004-3318","observed_orcids":["https://orcid.org/0000-0002-4004-3318"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Koen Schipper","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-4004-3318","affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5061098872","display_name":"Clare M. Isacke","orcid":"https://orcid.org/0000-0002-9222-3345","observed_orcids":["https://orcid.org/0000-0002-9222-3345"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Clare M. Isacke","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-9222-3345","affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","score":0.49779999256134033,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","score":0.49779999256134033,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10253","display_name":"Sarcoma Diagnosis and Treatment","score":0.16459999978542328,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.027300000190734863,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/endo180","display_name":"Endo180","score":0.9570000171661377},{"id":"https://openalex.org/keywords/mrc2","display_name":"MRC2","score":0.9760000109672546},{"id":"https://openalex.org/keywords/antibody-drug-conjugates","display_name":"antibody-drug conjugates","score":0.9860000014305115},{"id":"https://openalex.org/keywords/sarcoma","display_name":"sarcoma","score":0.9750000238418579},{"id":"https://openalex.org/keywords/immunoglobulins","display_name":"immunoglobulins","score":0.5080000162124634},{"id":"https://openalex.org/keywords/antibody-dilution","display_name":"antibody dilution","score":0.6729999780654907}],"concepts":[{"id":"https://openalex.org/C45235069","wikidata":"https://www.wikidata.org/wiki/Q278425","display_name":"Table (database)","level":2,"score":0.6341999769210815},{"id":"https://openalex.org/C197336794","wikidata":"https://www.wikidata.org/wiki/Q5161150","display_name":"Conjugate","level":2,"score":0.5619999766349792},{"id":"https://openalex.org/C2778256501","wikidata":"https://www.wikidata.org/wiki/Q223911","display_name":"Sarcoma","level":2,"score":0.5108000040054321},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.4729999899864197},{"id":"https://openalex.org/C33923547","wikidata":"https://www.wikidata.org/wiki/Q395","display_name":"Mathematics","level":0,"score":0.4075999855995178},{"id":"https://openalex.org/C26004113","wikidata":"https://www.wikidata.org/wiki/Q3711784","display_name":"Conjugate prior","level":4,"score":0.2727000117301941},{"id":"https://openalex.org/C41008148","wikidata":"https://www.wikidata.org/wiki/Q21198","display_name":"Computer science","level":0,"score":0.26170000433921814},{"id":"https://openalex.org/C154945302","wikidata":"https://www.wikidata.org/wiki/Q11660","display_name":"Artificial intelligence","level":1,"score":0.2540999948978424},{"id":"https://openalex.org/C105795698","wikidata":"https://www.wikidata.org/wiki/Q12483","display_name":"Statistics","level":1,"score":0.24889999628067017},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.22859999537467957}],"mesh":[],"locations_count":2,"locations":[{"id":"doi:10.1158/1535-7163.30733372","doi":"https://doi.org/10.1158/1535-7163.30733372","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1535-7163.30733372","pdf_url":"https://aacr.figshare.com/articles/journal_contribution/Supplementary_Table_S1_from_Endo180_i_MRC2_i_Antibody_Drug_Conjugate_for_the_Treatment_of_Sarcoma/30733372/1/files/59895127.pdf","source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},{"id":"pmh:oai:figshare.com:article/30733372","doi":null,"is_oa":true,"landing_page_url":"https://figshare.com/articles/journal_contribution/Supplementary_Table_S1_from_Endo180_i_MRC2_i_Antibody_Drug_Conjugate_for_the_Treatment_of_Sarcoma/30733372","pdf_url":null,"source":{"id":"https://openalex.org/S4377196282","display_name":"Figshare","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210132348","host_organization_name":"Figshare (United Kingdom)","host_organization_lineage":["https://openalex.org/I4210132348"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"Text"}],"best_oa_location":{"id":"doi:10.1158/1535-7163.30733372","doi":"https://doi.org/10.1158/1535-7163.30733372","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1535-7163.30733372","pdf_url":"https://aacr.figshare.com/articles/journal_contribution/Supplementary_Table_S1_from_Endo180_i_MRC2_i_Antibody_Drug_Conjugate_for_the_Treatment_of_Sarcoma/30733372/1/files/59895127.pdf","source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.8223000168800354}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4416764384.pdf","grobid_xml":"https://content.openalex.org/works/W4416764384.grobid-xml"},"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4309327225","https://openalex.org/W4416764614","https://openalex.org/W4392689970","https://openalex.org/W4416764646","https://openalex.org/W4416764716","https://openalex.org/W7100326730","https://openalex.org/W2217398072","https://openalex.org/W4362492970","https://openalex.org/W2737769268","https://openalex.org/W4416764643"],"abstract_inverted_index":{"Antibodies":[0],"and":[1],"their":[2],"dilutions":[3]},"counts_by_year":[],"updated_date":"2026-11-09T13:22:03.289127","created_date":"2025-10-24T00:00:00"}